The following companies are expected to report earnings prior to market open on 12/23/2024. Visit our Earnings Calendar for a full list of expected earnings releases.
Anavex Life Sciences Corp. (AVXL)is reporting for the quarter ending September 30, 2024. The biomedical (gene) company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.17. This value represents a 41.67% decrease compared to the same quarter last year. In the past year AVXL has met analyst expectations once and beat the expectations the other three quarters. The "days to cover" for this stock exceeds 12 days. Zacks Investment Research reports that the 2024 Price to Earnings ratio for AVXL is -15.40 vs. an industry ratio of -1.30.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
